On June 29, 2023, NovMetaPharma Co., Ltd. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,200 KRW | +0.32% | +0.16% | +67.57% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
20,500 KRW | +2.24% | -.--% | 133M | ||
6,200 KRW | +0.32% | +0.16% | 299M | ||
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+67.57% | 299M | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
-9.14% | 11.95B | |
+5.24% | 8.71B | |
-8.42% | 8.12B |
- Stock Market
- Equities
- A256840 Stock
- News BNC Korea Co., Ltd.
- NovMetaPharma Co., Ltd. announced that it has received KRW 6.99999258 billion in funding from BNC Korea Co., Ltd.